Poland· PL-100130099
Arilin Rapid
A metronidazole product containing metronidazolum, registered in Poland by Dr. August Wolff GmbH & Co. Arzneimittel. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Metronidazole is registered in 13 of 19 countries.
Countries holding a registration under ATC G01AF01 (metronidazole), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Metronidazole · ATC G01AF01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of metronidazole costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Metronidazole · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.75
The record
At a glance
URPL (Poland)- Active substance
- Metronidazolum
- Manufacturer
- Dr. August Wolff GmbH & Co. Arzneimittel
- Country
- Poland (PL)
- ATC code
- G01AF01
- ATC class
- Metronidazole
- Defined daily dose
- 0.5 g, V
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991102418
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
11 interactions on record for metronidazole.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metronidazole · interactions on record
11 records
- 1 severe
- 10 moderate
Most severe, free to view
- AmprenavirJ05AE05severe
- WarfarinB01AA03moderate
- EthanolB05XX04moderate
- RitonavirJ05AE03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G01AF01
Metronidazole, as other registers publish it.
- GermanyArilinDr. August Wolff Gmbh & Co. Kg Arzneimittel
- SwitzerlandArilin 1000 mg, VaginalzäpfchenAlcina AG
- SwitzerlandArilin 1000 mg, VaginalzäpfchenAlcina AG
- PolandArilin rapidMedezin Sp. z o.o.
- PolandArilin RapidInPharm Sp. z o.o.
- PolandArilin RapidInPharm Sp. z o.o.
- GermanyArilin RapidDr. August Wolff Gmbh & Co. Kg Arzneimittel
- FinlandElyzolAlpharma ApS
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08742d32-48a0-4318-953b-54c0bc038c24 GET /v1/drugs/08742d32-48a0-4318-953b-54c0bc038c24?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Globulki",
"source": "urpl",
"strength": "1000 mg",
"packaging": "05909991102418 ¦ Rp ¦ 24944\n2 szt.",
"substance": "Metronidazolum 1000 mg",
"common_name": "Metronidazolum",
"pl_product_id": "100130099",
"pozwolenie_nr": "11024",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about metronidazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.